<table id="t1" width="100%" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1 - Major Outcomes of the NSABP B-24 Trial</caption>
<col align="left" width="26.231%"></col>
<col align="left" width="12.416%"></col>
<col align="left" width="12.816%"></col>
<col align="left" width="12.544%"></col>
<col align="left" width="12.673%"></col>
<col align="left" width="12.660%"></col>
<col align="left" width="12.660%"></col>
<tfoot>
<tr><td align="left" colspan="7" valign="top"><paragraph stylecode="footnote"><sup>1</sup>Updated follow-up data (median 8.1 years)</paragraph></td></tr>
</tfoot>
<tbody>
<tr><td align="left" stylecode="Toprule Botrule Lrule Rrule" valign="middle"><content stylecode="bold">Type of Event</content></td><td align="center" colspan="2" stylecode="Toprule Botrule Rrule" valign="middle"><content stylecode="bold">Lumpectomy,</content><br/><content stylecode="bold">radiotherapy, and placebo</content></td><td align="center" colspan="2" stylecode="Toprule Botrule Rrule" valign="middle"><content stylecode="bold">Lumpectomy,</content><br/><content stylecode="bold">radiotherapy, and</content><br/><content stylecode="bold">tamoxifen</content></td><td align="center" stylecode="Toprule Botrule Rrule" valign="middle"><content stylecode="bold">RR</content></td><td align="center" stylecode="Toprule Botrule Rrule" valign="middle"><content stylecode="bold">95% CI Limits</content></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="bottom"><content stylecode="bold">No. of Events</content></td><td align="center" stylecode="Botrule Rrule" valign="bottom"><content stylecode="bold">Rate per</content><br/><content stylecode="bold">1000 women</content><br/><content stylecode="bold">per year</content></td><td align="center" stylecode="Botrule Rrule" valign="bottom"><content stylecode="bold">No. of Events</content></td><td align="center" stylecode="Botrule Rrule" valign="bottom"><content stylecode="bold">Rate per</content><br/><content stylecode="bold">1000 women</content><br/><content stylecode="bold">per year</content></td><td align="center" stylecode="Botrule Rrule" valign="bottom"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top"><content stylecode="bold">Invasion breast cancer<br/>  (Primary endpoint)</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">74</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">16.73</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">44</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">9.60</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">0.57</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">0.39 to 0.84</content></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  lpsilateral</td><td align="center" stylecode="Botrule Rrule" valign="top">47</td><td align="center" stylecode="Botrule Rrule" valign="top">10.61</td><td align="center" stylecode="Botrule Rrule" valign="top">27</td><td align="center" stylecode="Botrule Rrule" valign="top">5.90</td><td align="center" stylecode="Botrule Rrule" valign="top">0.56</td><td align="center" stylecode="Botrule Rrule" valign="top">0.33 to 0.91</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Contralateral</td><td align="center" stylecode="Botrule Rrule" valign="top">25</td><td align="center" stylecode="Botrule Rrule" valign="top">5.64</td><td align="center" stylecode="Botrule Rrule" valign="top">17</td><td align="center" stylecode="Botrule Rrule" valign="top">3.71</td><td align="center" stylecode="Botrule Rrule" valign="top">0.66</td><td align="center" stylecode="Botrule Rrule" valign="top">0.33 to 1.27</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Side undetermined</td><td align="center" stylecode="Botrule Rrule" valign="top">2</td><td align="center" stylecode="Botrule Rrule" valign="top">—</td><td align="center" stylecode="Botrule Rrule" valign="top">0</td><td align="center" stylecode="Botrule Rrule" valign="top">—</td><td align="center" stylecode="Botrule Rrule" valign="top">—</td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top"> <content stylecode="bold">Secondary Endpoint</content></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top"> <content stylecode="bold">DCIS</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">56</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">12.66</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">41</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">8.95</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">0.71</content></td><td align="center" stylecode="Botrule Rrule" valign="top"><content stylecode="bold">0.46 to 1.08</content></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  lpsilateral</td><td align="center" stylecode="Botrule Rrule" valign="top">46</td><td align="center" stylecode="Botrule Rrule" valign="top">10.40</td><td align="center" stylecode="Botrule Rrule" valign="top">38</td><td align="center" stylecode="Botrule Rrule" valign="top">8.29</td><td align="center" stylecode="Botrule Rrule" valign="top">0.88</td><td align="center" stylecode="Botrule Rrule" valign="top">0.51 to 1.25</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Contralateral</td><td align="center" stylecode="Botrule Rrule" valign="top">10</td><td align="center" stylecode="Botrule Rrule" valign="top">2.26</td><td align="center" stylecode="Botrule Rrule" valign="top">3</td><td align="center" stylecode="Botrule Rrule" valign="top">0.65</td><td align="center" stylecode="Botrule Rrule" valign="top">0.29</td><td align="center" stylecode="Botrule Rrule" valign="top">0.05 to 1.13</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  All Breast Cancer Events</td><td align="center" stylecode="Botrule Rrule" valign="top">129</td><td align="center" stylecode="Botrule Rrule" valign="top">29.16</td><td align="center" stylecode="Botrule Rrule" valign="top">84</td><td align="center" stylecode="Botrule Rrule" valign="top">18.34</td><td align="center" stylecode="Botrule Rrule" valign="top">0.63</td><td align="center" stylecode="Botrule Rrule" valign="top">0.47 to 0.83</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  All ipsilateral events</td><td align="center" stylecode="Botrule Rrule" valign="top">96</td><td align="center" stylecode="Botrule Rrule" valign="top">21.70</td><td align="center" stylecode="Botrule Rrule" valign="top">65</td><td align="center" stylecode="Botrule Rrule" valign="top">14.19</td><td align="center" stylecode="Botrule Rrule" valign="top">0.65</td><td align="center" stylecode="Botrule Rrule" valign="top">0.47 to 0.91</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  All contralateral events</td><td align="center" stylecode="Botrule Rrule" valign="top">37</td><td align="center" stylecode="Botrule Rrule" valign="top">8.36</td><td align="center" stylecode="Botrule Rrule" valign="top">20</td><td align="center" stylecode="Botrule Rrule" valign="top">4.37</td><td align="center" stylecode="Botrule Rrule" valign="top">0.52</td><td align="center" stylecode="Botrule Rrule" valign="top">0.29 to 0.92</td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Deaths</td><td align="center" stylecode="Botrule Rrule" valign="top">32</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top">28</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Uterine Malignancies<sup>1</sup></td><td align="center" stylecode="Botrule Rrule" valign="top">4</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top">9</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Endometrial Adenocarcinoma<sup>1</sup></td><td align="center" stylecode="Botrule Rrule" valign="top">4</td><td align="center" stylecode="Botrule Rrule" valign="top">0.57</td><td align="center" stylecode="Botrule Rrule" valign="top">8</td><td align="center" stylecode="Botrule Rrule" valign="top">1.15</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Uterine Sarcoma<sup>1</sup></td><td align="center" stylecode="Botrule Rrule" valign="top">0</td><td align="center" stylecode="Botrule Rrule" valign="top">0.0</td><td align="center" stylecode="Botrule Rrule" valign="top">1</td><td align="center" stylecode="Botrule Rrule" valign="top">0.14</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Second primaly malignancies<br/>  (other than endometrial and breast)</td><td align="center" stylecode="Botrule Rrule" valign="top">30</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top">29</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Stroke</td><td align="center" stylecode="Botrule Rrule" valign="top">2</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top">7</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
<tr><td align="left" stylecode="Botrule Lrule Rrule" valign="top">  Thromboembolic events<br/>  (DVT, PE)</td><td align="center" stylecode="Botrule Rrule" valign="top">5</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top">15</td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td><td align="center" stylecode="Botrule Rrule" valign="top"></td></tr>
</tbody>
</table>